CIDRAP newsletters options
The next steps include fleshing out mechanisms for benefit sharing, financing, and supply chain logistics.
The outbreak of Shigella flexneri sickened 202 people in Albuquerque and 16 non-human primates at a local zoo.
Critics said today’s announcement is more evidence of the current administration’s willingness to undermine public trust in vaccines.
They reported seeing bats and coming into contact with bat droppings while crawling through tight spaces during the 2-hour tour.
Georgia reported its fourth case, a resident of the Atlanta area who had traveled internationally.
The outbreak has sickened 26 people in 15 states and is linked to a grower and distributor in Florida.
In other H5N1 developments, the USDA confirms an outbreak at an Arizona layer farm that has more than 2 million birds.
Fifty-seven percent of those polled said they were unsure of complications if a pregnant woman contracts measles.
The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
A separate study found that 72% of infants were protected against RSV through maternal vaccination or infant receipt of nirsevimab in 2023-24.
Today a committee overwhelmingly approved the measure, 3 years in the making, which is up for a final vote in the plenary session tomorrow.
Analysis of hospitalized patients with community-acquired pneumonia links azithromycin to lower mortality and more hospital-free days compared with doxycycline in combination with beta-lactams.
Both the Moderna and Pfizer mRNA vaccines carried the same 15% increased risk of an extended menstrual cycle.
Texas remains the country's hot spot, with 718 cases.
On viral culture, 4 of 21 environmental samples (19%) contained infectious virus.
When CDC advisers widened their recommendation in 2023, most members were swayed by data, including those for long COVID, showing that no group is at low risk for the virus.
Wastewater levels for COVID-19 are low, while for influenza A and RSV they are very low.
Five countries in the Americas have confirmed 212 recent cases and 85 deaths, for a death rate of 40%.
Patients who received the rVSV-ZEBOV vaccine were 1.7 times less likely to die than their unvaccinated peers.
The median treatment duration for uncomplicated gram-negative BSIs at 24 US hospitals was 11 days, with marked variation among hospitals.
